Results 61 to 70 of about 8,273,044 (312)

Molecular medicine techniques in the detection of viral hepatitis

Global Journal of Medicine and Public Health, 2015
Viral hepatitis is a major concern in the public health scenario which has been the root cause of serious adverse events affecting the human population. Molecular diagnostics has paved the way for an incredible role in the advancement of the
Jayanta Borkakoti , Giassuddin Ahmed, Premashis Kar   +2 more
doaj  

Engineering Microbial Particles for Next‐Generation Biomedical Platforms

Advanced Science, EarlyView.
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li, Yunjie Lu, Ziyan Huang, Jianjiang Chen, Yanbin Liu, Lei Qin, Chao Wang, Yumin Wu   +7 more
wiley   +1 more source

Association of Hepatitis C Virus (HCV) Infection and Human Leukocyte Antigens (HLA)

Diyala Journal of Medicine, 2019
Back ground: Several previous reports on the association between hepatitis C virus (HCV) infection and certain human leukocyte antigens (HLA) have yielded controversial results.
Abdul-Razak SH Hasan , Karim Sadun Ali Al-Ajeeli   +1 more
doaj   +2 more sources

Post-transplant liver biopsies: a concise and practical approach for beginners [PDF]

Journal of Pathology and Translational Medicine
Exposure to post-transplant liver biopsies varies among pathology residencies and largely depends on the institution's training program, particularly if the hospital has a liver transplant program.
Mohamad Besher Ourfali, David Hirsch, Marianna Scranton, Tony El Jabbour   +3 more
doaj   +1 more source

Viral hepatitis surveillance report : United States, 2019 [PDF]

The Centers for Disease Control and Prevention (CDC) collects, analyzes, and disseminates viral hepatitis surveillance data. Each week, staff at health departments submit case reports of viral hepatitis to CDC through the National Notifiable Diseases ...

core  

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection [PDF]

, 2002
Deletion, anergy, and a spectrum of functional impairments can affect virus-specific CD8 cells in chronic viral infections. Here we characterize a low frequency population of CD8 cells present in chronic hepatitis B virus (HBV) infection which survive in
Ogg, GS, Antonio Bertoletti, Brown, D., Dusheiko, G., Brown, D, Geoff Dusheiko, Williams, R., George J.M. Webster, Webster, GJ, Seneviratne, SL, Webster, G.J.M., Reignat, S, David Brown, Mala K. Maini, Stephanie Reignat, King, A., Dusheiko, G, Maini, MK, Bertoletti, A, Suranjith L. Seneviratne, Roger Williams, King, A, Bertoletti, A., Reignat, S., Williams, R, Maini, M.K., Graham S. Ogg, Abigail King, Ogg, G.S., Seneviratne, S.L.   +29 more
core   +1 more source

Targeting p21‐High Senescent Kupffer Cells Nanotherapeutically Potentiates Antitumor Immunity in Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Advanced Science, EarlyView.
Schematic illustration of a biomimetic SKEV@AAV platform targeting p21‐high senescent Kupffer cells (sKCs) in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). p21‐high sKCs accumulate in the PVTT microenvironment and establish an immunosuppressive, SASP‐rich environment that facilitates tumor cell proliferation and immune evasion.
Na Ta, Shuyi Wang, Boyan Zhang, Ning Liu, Yingchen Han, Aoran Liu, Ying Xu, Tingsong Chen, Ye Zhang, Qiuhua Luo, Tao Han   +10 more
wiley   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

Hepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou   +13 more
wiley   +1 more source

Hepatitis B and C Virus Co-Infection and Their Association With Liver Disease in Persons With HIV in Nigeria

Journal of the International Association of Providers of AIDS Care
Background: The burden of chronic viral hepatitis among people living with human immunodeficiency virus (PLWH) and its association with liver disease in Nigeria has been seldom explored.
Emuobor Odeghe MBBS, FWACP, MS, Ganiyat Oyeleke MBBS, FMCP, MScPH, Mayowa Odofin MBBS, MPH, Mary Duguru MBBS, FWACP, Pantong Davwar MBBS, FWACP, FMCP, David Nyam MBBS, FWACP, Olufunmilayo Lesi MD, FWACP, FMCP, FRCP, Edith Okeke BmBcH, FWACP, FRCP, Hameed Adelabu BSc, Oluwakemi Odukoya MBBS, MPH, MSc, FMCPH, FRSPH, Alani Akanmu MBBS, FMCPath, MD, Wasiu Adeyemo BDS, FMCDS, FWACS, PhD, Fatimah Abdulkareem MBBCh, MD, FMCPath, Godwin Imade MSc, PGD, PhD, Brian Joyce PhD, Imran Khan BS, MS, MBA, Ariel Chandler PhD, Atiene Sagay MBChB, FWACS, FRCOG, Robert Murphy MD, Lifang Hou MD, MS, PhD, Claudia Hawkins MD, MPH   +20 more
doaj   +1 more source

Regulation of viral replication by host restriction factors

Frontiers in Immunology
Viral infectious diseases, caused by numerous viruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus (IAV), enterovirus (EV), human immunodeficiency virus (HIV), hepatitis B virus (HBV), and human papillomavirus
Ying Lin, Ying Lin, Ying Lin, Yun Zhu, Yun Zhu, Ling Jing, Ling Jing, Ling Jing, Xiaobo Lei, Xiaobo Lei, Zhengde Xie, Zhengde Xie   +11 more
doaj   +1 more source